Alto Neuroscience, Inc. (ANRO)
19.91
+0.23
(+1.17%)
USD |
NYSE |
Jun 11, 09:47
Alto Neuroscience EPS Diluted (TTM) : -2.482 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.482 |
| December 31, 2025 | -2.245 |
| September 30, 2025 | -2.301 |
| June 30, 2025 | -2.400 |
| March 31, 2025 | -2.341 |
| December 31, 2024 | -2.280 |
| September 30, 2024 | -2.133 |
| Date | Value |
|---|---|
| June 30, 2024 | -1.868 |
| March 31, 2024 | -1.596 |
| December 31, 2023 | -1.097 |
| September 30, 2023 | -0.9791 |
| June 30, 2023 | -0.6217 |
| March 31, 2023 | -0.2995 |
| December 31, 2022 | -0.2992 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Bristol Myers Squibb Co. | 3.563 |
| NRX Pharmaceuticals, Inc. | -1.278 |
| LB Pharmaceuticals, Inc. | -1.486 |